Saussele S, Richter J, Guilhot J, et al. "Duration of Deep Molecular Response" Has Most Impact on the Success of Cessation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - Results from the EURO-SKI Trial. ASH 59th Annual Meeting & Exhibition, abstract 313.
PRO’s bij patiënten met FLT3-ITD-positieve AML die chemotherapie plus quizartinib ontvangen
mei 2026 | Leukemie